Next‐generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trial

Eltrombopag has been previously shown to be effective in reversing azacitidine‐mediated thrombocytopenia. This was further investigated in the SUPPORT trial, a phase III study assessing the efficacy/safety of eltrombopag plus azacitidine in patients with intermediate‐ to high‐risk myelodysplastic sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Pedro Marques, Choi, Jeea, Campbell, Catarina D., Wang, Ying A., Pallaud, Celine, Dickinson, Michael, Verma, Amit, Mittelman, Moshe, Platzbecker, Uwe, Cherif, Honar, Fenaux, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435669/
https://www.ncbi.nlm.nih.gov/pubmed/37601870
http://dx.doi.org/10.1002/jha2.694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435669/
https://www.ncbi.nlm.nih.gov/pubmed/37601870
http://dx.doi.org/10.1002/jha2.694

Ejemplares similares